View Cart  

Investigation of Abiomed Marketing Practices Shadows Strong Quarter

A A
Cardiac devicemaker Abiomed is under scrutiny for its marketing and labeling of the Impella 2.5 heart pump, the company said in a Nov. 1 earnings statement covering the second quarter of fiscal 2013.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00